by ninedot | Jul 13, 2017
Tregitope Publications Dembele M, Tao S, Massoud AH, Miah SM, Lelias S, De Groot AS, Mazer BD. Tregitopes Improve Asthma by Promoting Highly Suppressive and Antigen-Specific Tregs. Frontiers in Immunology. April 2021. doi: 10.3389/fimmu.2021.634509. Full Text ...
by ninedot | Jul 13, 2017
Tregitope Applications Tregitopes are a highly specialized means of suppressing immune responses and inflammation. Thus there may be a Tregitope application for many situations where there is an unwanted immune response. This includes immune reactions to foreign...
by Annie De Groot | Apr 25, 2017 | Featured, News, Thinking Out Loud -Blog
EpiVax Signs First Commercial License for Tregitope Technology PROVIDENCE, R.I., April 25, 2017 – Providence-based biotechnology company EpiVax, Inc. (“EpiVax”) has licensed its novel immune-modulating technology to an undisclosed global...
by Annie De Groot | Apr 7, 2017 | News
Providence, RI April 7th, 2017 Providence-based biotechnology company EpiVax, Inc. (“EpiVax”) has licensed its novel immune-modulating technology to an unnamed global pharmaceutical company, for use in autoimmune disease and allergy. Tregitopes, pronounced...
by Admin Epivax | Aug 2, 2016
Tregitope: Immunomodulation Power Tool Tregitopes, discovered by Anne De Groot and Bill Martin at EpiVax, are linear sequences of amino acids contained within the framework of monoclonal antibodies and immunoglobulin G that activate natural regulatory T cells....
